TEIJIN LIMITED Flash Report
FY2016 Financial Performance
&
FY2017 Outlook
Teijin Limited
May 9, 2017
Outline of FY2016 Results
1. Outline of FY2016 Results
1) Consolidated results highlights
Full-Term Operating Movement
Net Sales Operating Income
Profit (loss) Attributable to Owners of Parent*
Free Cash Flow
(¥ billion)
-6.3% -15.8% +61.3%
790.7 40.3 741.3 67.1 56.5 50.1 31.1FY2015 FY2016
FY2015 FY2016 FY2015FY2016
(48.6)FY2015 FY2016
＊Historical record high profit in the past: ¥34.1 billion (FY2006) 2
1. Outline of FY2016 Results
FY2015 | FY2016 | Difference | |
Net sales | 790.7 | 741.3 | -49.5 |
Operating income | 67.1 | 56.5 | -10.6 |
Net sales: Declined, owing to Impact of optimizing our production configuration associated with restructuring initiatives mainly in the resin business, in addition to the stronger yen in the first half of FY 16, although sales were generally steady across all businesses on the whole Operating income and Ordinary income: Declined owing to New drug licensing costs and the impact of foreign exchange movements, despite efforts to steadily improve profitability by driving growth in existing businesses and executing restructuring initiatives Profit attributable to owners of parent: Up sharply, owing to A decrease in tax expense exceeding extraordinary losses | |||
OP margin | 8.5% | 7.6% | -0.9% |
Nonoperating items (net) | (6.8) | (0.6) | +6.2 |
Ordinary income | 60.3 | 55.9 | -4.4 |
Extraordinary items (net) | (14.7) | (22.0) | -7.3 |
Income before income taxes | 45.6 | 33.9 | -11.7 |
Income taxes | 16.4 | (17.5) | -33.8 |
Profit attributable to non- controlling interests | (1.9) | 1.3 | +3.1 |
Profit attributable to owners of parent | 31.1 | 50.1 | +19.0 |
Earnings per share*1 (¥) | 158.1 | 254.9 | +96.8 |
Operating results
(¥ billion)
Posted record-high profit due partly to a decrease in tax expense following
a decision to withdraw from home healthcare business in the U.S.
exchange rate | FY15 Average | FY16 Average |
¥/US$ | 120 | 108 |
¥/€ | 133 | 119 |
US$/€ | 1.10 | 1.10 |
EBITDA *2 | 106.0 | 95.8 | -10.2 |
CAPEX *3 | 38.3 | 46.2 | +7.9 |
Depreciation & amortization | 38.9 | 39.3 | +0.4 |
R&D expenses | 33.3 | 35.4 | +2.1 |
Free Cash Flow | 40.3 | (48.6) | -88.9 |
◇PL
*1 In connection with the consolidation of shares conducted on October 1,
2016, figures were calculated as if the consolidation of shares had been conducted at the beginning of the previous fiscal year
*3 CAPEX includes investments in intangible assets *2 EBITDA = Operating income + Depreciation & amortization 3
Teijin Limited published this content on 09 May 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 09 May 2017 02:37:02 UTC.
Original documenthttps://www.teijin.com/ir/library/presentation_materials/pdf/pm_170509.pdf
Public permalinkhttp://www.publicnow.com/view/1436E5178E4C6894C06DBF6A781B435AAB3B1244
